Default: Current Opinion in Biotechnology

ISSN: 0958-1669

Journal Home

Journal Guideline

Current Opinion in Biotechnology Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 202. It has a price of 2100 €. It has an SJR impact factor of 2,843 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,843.

Current Opinion in Biotechnology focuses its scope in these topics and keywords: bacteria, expression, systems, protein, metabolic, design, plant, engineering, cyanobacteriatools, crop, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2100 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Current Opinion in Biotechnology

2,843

SJR Impact factor

202

H Index

193

Total Docs (Last Year)

475

Total Docs (3 years)

11888

Total Refs

4236

Total Cites (3 years)

444

Citable Docs (3 years)

9,14

Cites/Doc (2 years)

61,60

Ref/Doc

Other journals with similar parameters


Nature Microbiology Q1
Nature Biomedical Engineering Q1
Nano Today Q1
PLoS Medicine Q1
BMC Biology Q1

Compare this journals

Aims and Scope


bacteria, expression, systems, protein, metabolic, design, plant, engineering, cyanobacteriatools, crop, containment, engineered, engineeringnoncanonical, engineeringsynthetic, environment, enzyme, escherichia, constructionthe, compoundsexploration, common, aerobic, amino, analysischemicalinducible, approach, biomaterialsharnessing, biomaterialspeptide, bugs, cereal, chlorinated, colimodular, cometabolism,



Best articles by citations

BiotechnologyPaper alert

View more

Public reactions and scientific responses to transgenic cropsCommentary

View more

Fermentation technologies for the production of probiotics with high viability and functionality

View more

Forest tree biotechnology

View more

VEGF and therapeutic opportunities in cardiovascular diseases

View more

Paper alert: Biotechnology

View more

Current and emerging technologies for the study of bacteria in the outdoor air

View more

Light at the end of the tunnel: from genes to function

View more

Implications of sequencing bacterial genomes for pathogenesis and vaccine development

View more

Differences among mechanisms of ribozyme-catalyzed reactions

View more

The past and future of structure databases

View more

Engineering the mouse genome by site-specific recombination

View more
SHOW MORE ARTICLES

Engineered liver for transplantation

View more

Bioprocessing of therapeutic proteins

View more

tRNA-mediated protein engineering

View more

Progress in plant metabolic engineering

View more

Plant biotechnology

View more

Antiangiogenic agents

View more

Plant biotechnology Biochemical engineering

View more

Mammals, plants, bacteria, and soil: common problems and solutions in gene expression and analysis

View more

Structures of redox enzymes

View more

NMR spectroscopy in structure-based drug design

View more

Neutron scattering: good news for biotechnology

View more

Protein technologies and commercial enzymes

View more

Comments

No comments ... Be the first to comment!

FAQS